Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
CAPRIUS INCListing unverified | Sell | $6.3K | SEC | |
CAPRIUS INCListing unverified | Sell | $239.6K | SEC | |
CAPRIUS INCListing unverified | Sell | $14.5K | SEC | |
ChemoCentryx, Inc.Listing unverified | Sell | $348.5K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $394K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $4.2M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $1M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $391.5K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $771.2K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $8.2M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $202.4K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $1.3M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $691.2K | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $1.4M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $11.5M | SEC | |
LIGAND PHARMACEUTICALS INCListing on record | Sell | $1.2M | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $27K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $176.6K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $56.2K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $39.3K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $371.2K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $161.5K | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $3.9M | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $2.1M | SEC | |
ChemoCentryx, Inc.Listing unverified | Buy | $280.2K | SEC |